Navigation Links
Antidepressant as Good as Antipsychotics for Dementia
Date:9/10/2007

Study finds fewer side effects for Alzheimer's patients prone to hallucinations, delusions

MONDAY, Sept. 10 (HealthDay News) -- The antidepressant citalopram (Celexa) may be as effective as often-prescribed antipsychotic drugs to control the agitation and psychotic symptoms associated with dementia, a new study suggests.

Agitation and psychotic symptoms are often more disturbing than the memory loss associated with Alzheimer's and other forms of dementia and are also the most difficult challenge for family members caring for an elderly person. Currently, antipsychotic drugs such as risperidone (Risperdal) are used to control these symptoms. But often the side effects, including sedation, tension and apathy, can be debilitating, the study authors said.

"We found that an antidepressant worked as well in severely agitated patients suffering from Alzheimer's disease as an antipsychotic," said lead researcher Dr. Bruce Pollock, of the University of Toronto's Department of Psychiatry. "And citalopram had fewer side effects."

The surprise was that citalopram worked as well for psychotic symptoms such as delusion and visual hallucinations, he said.

Pollock also noted that antipsychotic drugs have an increased risk of death associated with their use. "But, for the first time, it has been shown that an antidepressant may work as well for psychotic symptoms as an antipsychotic," he said.

Pollock thinks the antidepressant worked, because the psychotic symptoms associated with dementia have a different chemistry than the same symptoms in a psychotic patient.

For the study, Pollock's team randomly assigned 103 patients who were hospitalized at the University of Pittsburgh Medical Center with psychiatric disturbances related to dementia to receive either citalopram or risperidone. Fifty-three patients received daily doses of citalopram, while 50 got daily doses of risperidone.

After 12 weeks, the researchers found that both drugs had a similar effect in relieving psychotic symptoms, such as hallucinations, delusions and suspicious thoughts. There was a 32 percent reduction in symptoms among patients receiving citalopram, compared to a 35 percent reduction among those receiving risperidone.

However, there was a significant 19 percent increase in side effects with risperidone, compared with a 4 percent decrease among patients taking citalopram, the researchers reported.

Their findings are published in the Sept. 10 online edition of the American Journal of Geriatric Psychiatry.

If further studies replicate these findings, Pollock thinks antidepressants could be a viable alternative to antipsychotic drugs for Alzheimer's patients.

"Behavioral disturbances are the most terrible thing that patients and caregivers have to cope with in dementia," he said. "And 90 percent of Alzheimer's patients will experience them. It's the phenomena that results in patients going to nursing homes and requiring higher levels of care."

One expert thinks these findings are promising but need to be confirmed before they can be put into clinical practice.

"This is an interesting direction for further research," said Dr. Ralph A. Nixon, a professor of psychiatry and cell biology at New York University School of Medicine and a member of the Alzheimer's Association's medical and scientific advisory council. "It is a preliminary indication of a new class of medications to treat something that has been a very vexing problem to treat."

Nixon thinks these drugs need to be compared with placebos to gauge the true effect of antidepressants on the psychotic symptoms associated with Alzheimer's.

"Based on these findings, we shouldn't go out there and replace the drugs that are the current standard with something where the jury is still out as to its efficacy," he said.

More information

For more on Alzheimer's disease, visit the Alzheimer's Association.



SOURCES: Bruce Pollock, M.D., Department of Psychiatry, University of Toronto, Canada; Ralph A. Nixon M.D., Ph.D., professor, psychiatry and cell biology, New York University School of Medicine, New York City, and member, Alzheimer's Association's medical and scientific advisory council; Sept. 10, 2007, American Journal of Geriatric Psychiatry, online


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
2. Antidepressant helps obesity
3. Antidepressants increase gastric bleeding
4. Antidepressants-important role
5. Antidepressants increase gastric bleeding
6. Antidepressants could pose grave implications
7. Antidepressant Helps Relieve Hot Flashes
8. Antidepressants May Benefit Heart Patients
9. Antidepressants Harmful for Kids
10. Antidepressants For Children: How safe is it ?
11. Antidepressants Late In Pregnancy Harmful to Unborn Baby
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... an excellent way to ensure moisture measurements are consistently correct. However, regular ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... they have teamed up with The American College of Surgeons (ACS) to provide ... on Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: